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Abstract
Aims and objectives The aim of this study is to determine the difference between clinical
pathway (CP) and conventional care in terms of health-related quality of life (HRQoL)
domains, depression and anxiety, as well as to determine the relative contribution of CP
towards an improved HRQoL after coronary artery bypass graft (CABG).
Method A longitudinal quasi-experimental pre-test/post-test design was used to study and
compare clinical outcome, HRQoL depression and anxiety for CP versus conventional-care
patients after CABG. HRQoL was measured by using Sf-36, while depression and anxiety
were measured by using hospital anxiety and depression scale. Length of stay and patient
complications were derived from the hospital database.
Results We found that implementing a CP decreased hospital delay from 2.50 (7.19) to
1.80 (1.60), which was statistically significant P = 0.002. We also found that patients in
the conventional-care plan improved more than patients in the CP in HRQoL. Outcomes in
favour of patients in the conventional-care trajectory were based on the difference between
small effect sizes (ES) (0.20 <0.50) for pathway patients and moderate ES (0.50 <0.80)
for conventional-care patients, except for the domain of physical functioning and physical
component summary, where the ES for conventional care was large (>0.80).
Conclusion The aim of designing and implementing pathways is to decrease length of stay
and costs, while maintaining quality of care and improving patient outcomes. Our findings
suggest that these aims were not fulfilled in this CABG pathway. We recommend that when
designing a CP, all patient-related characteristics, risk indicators, along with physiological
status, be taken into consideration.
Introduction
Nowadays, health-care professionals are faced with the challenge
of providing high-quality patient care, while simultaneously
cutting costs and decreasing in-hospital length of stay (LOS). This
challenge has made the use of clinical pathways (CPs) very
appealing, as a tool both for improving outcomes and for decreas-
ing costs during a specific LOS [1,2]. CPs are multidisciplinary
management plans that display goals for patients and provide the
corresponding ideal sequence and timing for staff action to achieve
those goals with optimal efficiency [2,3].
Clinical pathways, when applied to health care, have raised
obvious concerns; however, as there are individual patient factors
that may contribute to deviations from crucial elements in the
pathway plan, CPs have an effect on the outcome expected.
Factors such as these cannot be controlled by the pathway
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guidelines and so need to be considered when modelling the care
process. Pathway designers tend to address the ideal patient
without co-morbidities or complications, and so they do not
control for such confounding patient characteristics before assign-
ment to the pathway [1,4]. Thus, the heterogeneity of the effects of
CP, as compared with conventional care, may be because of lack
of attention to confounders. Differences in the methodological
quality of study designs may further add to this heterogeneity
[5,6].
According to our findings in an earlier systematic review [5] on
the efficacy of CPs, only 12 out of the 115 studies (10.4%) con-
trolled for selection bias by means of matching. Out of these, three
studies matched a random sample from a CP group with controls
from a pre-pathway-period group. Furthermore, most of these
studies focused on cost issues and reductions in LOS, while clini-
cally relevant outcomes such as discharge disposition, health-
related quality of life (HRQoL), depression, anxiety and care
dependency were largely ignored. Because there was a tendency to
report only the positive or neutral effects of CPs, the negative
effects of pathways were rarely reported. However, a systematic
review addressing in-hospital care pathways for stroke patients has
concluded that patient satisfaction and quality of life can be sig-
nificantly lower in the care pathway group, while at the same time
there was no significant difference in the LOS between the two
groups [6,7].
This same trend has emerged in the past decade in relation to
evaluating coronary artery bypass graft (CABG) pathways, ever
since more comparative cohort studies were conducted to detect
the effect of CABG pathways. It has been concluded that CABG
pathways did decrease LOS, costs [8–12] and complications [13],
but none of these studies provided any evidence regarding quality
of life or depression, and anxiety.
This stated, few investigators have used health-related function-
ing or quality-of-life measures as outcomes in order to detect
differences between pathway and conventional-care patients, and
have ended up finding that there is no difference between the two
groups in relation to HRQoL [14–16].
Generally speaking, it would appear to be difficult to detect
statistically significant and clinically relevant differences in trials
that evaluate care interventions such as nurse-led disease manage-
ment, case management and CPs [17,18] in coronary artery dis-
eases, chronic obstructive pulmonary disease and CABG [16].
This is largely because the main effects are induced by (medical)
treatments in both control and experimental groups.
In light of these findings, the aim of this study is to determine
the difference between CP and conventional care in terms of
HRQoL domains, depression and anxiety, as well as to determine




A longitudinal quasi-experimental pre-test/post-test design was
used to study and compare clinical outcome, HRQoL, depression
and anxiety for CP versus conventional-care patients 6 months
after CABG. A conventional randomization procedure was consid-
ered inappropriate. Randomizing individual patients (or surgeons)
to either a CP or a conventional care within the same hospital
invites contamination because many of the same doctors, as well
as care staff, are involved in treating the same population of
patients. Nevertheless, the assessment of patients’ outcomes was
done in ignorance of the method of care they were receiving.
We therefore used a historical control group and applied the
CONSORT criteria [19] for the reporting of randomized controlled
trials, finding this the best way to obtain information from this
study.
After inclusion, patients received a mailed questionnaire before
surgery, accompanied by an informed consent form. Follow-up
questionnaires were sent out 6 months after the CABG interven-
tion was executed. The questionnaires, once filled out, were
checked for completeness at baseline as well as at follow-up. If a
page was not filled in, a copy was sent with a request to please
complete the questions or, if it concerned one or fewer questions,
patients were interviewed by telephone. Because the completeness
of the questionnaire was monitored by a computer programme
both at baseline and follow-up, we effectively reduced the non-
response on questions and, consequently, on scales.
Patient selection
Consecutive patients, who were scheduled for CABG following a
coronary angiography, were recruited from October 2004 till
March 2005, and these constituted the control group receiving
conventional care. Patients scheduled for CABG with the applica-
tion of the CP were recruited from April 2005 till January 2006,
from both the University Medical Center Groningen in Groningen
and the Haga Hospital in The Hague, both in the Netherlands.
Patients with other incapacitating diseases, cognitive impairments,
admitted for emergent/urgent CABG, aged 80 and older, or who
did not speak Dutch were excluded. Ethical approval was obtained
from each participating hospital’s ethics committee. An overview
of patient selection for the current study is presented in Fig. 1.
A postal follow-up survey was sent out to 256 patients, both at
baseline and 6 months after CABG. The response rate at baseline
was 77.3% (198/256). When comparing included patients with
non-responders, no differences were found between the two
groups except with regard to gender (c2 = 4.85, d.f. = 1; P = 0.03),
with 33.3% vs. 21.2% women respectively. Compared with the
study baseline sample, dropouts at follow-up did not differ sys-
tematically for gender (c2 = 1.63, d.f. = 1; P = 0.20) and marital
status (c2 = 1.81, d.f. = 1; P = 0.18), nor for mean differences in
age (66.1 10.09 vs. 64.59 9.95; d.f. = 196; P = 0.45). Given
that we used a prospective design that included only patients with
complete questionnaire data at baseline and 6-month follow-up,
our analyses were finally based on 168 patients.
Procedure
The clinical pathway
The pathway targeted a maximum LOS of 8 days. Patients fol-
lowed the pathway designed from admission till discharge; the
pathway did not extend after discharge and did not include a
follow-up programme. In the preoperative period patients partici-
pated in an interactive educational session where they were
informed about their preparation for surgery by the cardiothoracic
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surgeon, the anaesthesiologist and the nurse practitioner. Patients
were also informed about what to expect during the preoperative
and post-operative periods, and were invited to express their feel-
ings of anxiety and their concerns about surgery and recovery.
Furthermore, the nurse practitioner and the physiotherapist pre-
pared patients for discharge by providing education about wound
care, the occurrence of complications, physical rehabilitation and
exercises, blood sugar and weight control. Patients who underwent
CABG in the control group followed the conventional trajectory




We obtained data on patient characteristics and medical status at
baseline. Age and gender were used as reported by patients in the
questionnaire. Being married, living with a partner or being a
widower were all classified as (1) living with a partner; divorced or
living alone were classified as (2) living alone. Educational status
was defined as (1) elementary schooling; (2) secondary schooling;
(3) higher professional training; and (4) college education/
university, based on the highest degree obtained. Work status was
defined as (0) working and (1) not working (with housewives
classified as working). Smoking was recorded as (0) not smoking
and (1) smoking. Type D personality was recorded as (0) type D
and (1) non-type D.
Medical variables and number of perioperative
complications
The Risk stratification model EuroSCORE was used to calculate
patients’ risk levels and patients were later classified into three risk
groups: (1) low (additive score of 0–2); (2) medium (scores 3–5);
and (3) high risk (scores 3–5) [20–24]. Data on preoperative and
post-operative medical and clinical characteristics, such as New
York Heart Association, angina, myocardial infarction, left ven-
tricular ejection fraction, chronic pulmonary disease, renal dis-
eases, diabetes, as well as post-operative events such as atrial or
ventricular arrhythmia, use of inotropes, re-exploration for bleed-
ing or tamponade, sternal re-suturing, time spent on mechanical
ventilation, were all retrieved from the registry database, medical
notes, outpatient notes and intensive therapy unit charts.
Patients admitted for 
CABG 
n = 307




at baseline n = 198 
Patients responded 
at follow-up 





Died                             n = 10 
Cancelled operation     n = 5 
Refused by letter         n = 1 
No response  
Without reason            n = 14 
Age > 75 years
Chronic disease       n = 18 
Scheduled for valve  
Replacement n = 8 
Too ill  n = 2 
Address unknown n =  5 
No interest n = 21 
No reason n = 30 
n = 25 
Figure 1 Overview of patient selection for
the current study. CABG, coronary artery
bypass graft.
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Type D personality
We used the Type D Scale (DS14) to assess the distressed (type D)
personality [25]. This scale consists of fourteen items that are
answered on a five-point Likert scale from 0 (false) to 4 (true).
Seven items tap negative affectivity, and seven items tap social
inhibition (score range, 0–28 for each subscale). Type D caseness
is defined by a high score on both subscales, as determined by a
standardized cut-off score 10 [25]. The DS14 is a valid and
reliable scale with Cronbach’s alpha = 0.88/0.86, and 3-month
test–retest reliability (r) = 0.72/0.82 for the negative affectivity and
social inhibition subscales respectively [25]. Type D personality is
more than just negative affect, because it also encompasses how
patients deal with this affect through the inclusion of the social
inhibition component [25]. The DS14 was administered at
baseline.
SF-36 (health-related quality of life)
The Short Form Health Survey (SF-36) was sent to patients pre-
operatively after they were scheduled for CABG, and post-
operatively 6 months after CABG. The SF-36 is a generic measure
that assesses eight HRQoL domains, that is, physical functioning,
role physical functioning, role emotional functioning, mental
health, vitality, social functioning, bodily pain and general health
[26]. Scale scores are obtained by summing the items together
within a domain, dividing this outcome by the range of scores and
then transforming these raw scores to a scale from 0 to 100. A
higher score on the SF-36 sub-domains represents better function-
ing, with a high score on the bodily pain scale indicating freedom
from pain. The scale has good reliability with Cronbach’s alpha
ranging from 0.65 to 0.96 for all subscales [27]. Later, the sub-
domains of the SF-36 were dichotomized, with the lowest tertile
indicating impaired health status [28–30].
Hospital anxiety and depression scale (HADS)
anxiety and depression
Anxiety and depressive symptoms were assessed at 6 months after
CABG by using the seven-item anxiety subscale and the seven-
item depression subscale from the HADS [31]. Responses to both
subscales are indicated on a four-point Likert Scale from 0 to 3
(score range 0–21). A cut-off score8 was used for both subscales
to identify patients with anxiety and depressive symptoms. This
cut-off has been shown to balance sensitivity and specificity opti-
mally [32]. The HADS has been shown to be a valid and reliable
instrument [32,33] and to predict mortality in patients referred for
exercise testing [34].
Hospital length of stay, readmission and
discharge destination
Length of hospital stay was calculated for each patient in three
time intervals: (1) days between date of admission and date of
discharge; (2) days between date of admission and date of opera-
tion; and (3) days between date of operation and discharge. Des-
tination after discharge was recorded and was defined as (0) home
or (1) other (including extended health-care facility, and nursing
homes, or hospitals). Readmission after operation because of
cardiac-related complaints was assessed 6 months after CABG.
Analysis
Discrete variables were compared by using the chi-square test
(Fisher’s exact test, when appropriate, and difference-of-
proportions test) [35], and were presented as numbers and percent-
ages. Continuous variables were normally distributed (Shapiro–
Wilk, P > 0.05), and were therefore compared with the Student
T-test, and are here presented as means SD. All statistical tests
were two-tailed. A value of P < 0.05 was used for all tests to
indicate statistical significance.
First, CP and conventional-care groups were compared at base-
line for sociodemographic and clinical characteristics, and the
effect sizes (ES) were calculated only for statistically significant
results, because differences between groups owing to sample fluc-
tuation had no clinical relevance. Cohen’s ES d for unrelated
samples was used to estimate the magnitude of the statistically
significant differences between CP and conventional-care groups
(mean difference score/the pooled standard deviation). According
to Cohen’s thresholds, an ES of <0.20 indicates a trivial difference,
an ES of 0.20 to <0.50 a small difference, an ES of 0.50 to
<0.80 a moderate one, and an ES 0.80 a substantial difference.
For differences in proportions between CP and conventional care,
Cohen’s ES statistic ‘w’ was used with a threshold of <0.10 for
trivial, >0.10 to <0.30 for small, >0.30 to <0.50 for medium, and
>0.50 for large differences [36].
Second, we estimated the amount of change between baseline
and follow-up for HRQoL, depression and anxiety across the CP
and conventional-care groups. The magnitude of change for each
scale of the SF-36 and HADS was estimated independently both in
the CP group and the control group with a standardized response
mean [37], and relative validity methodology [38,39] was used to
compare these ES across both groups. Relative efficacy index (RE)
coefficients estimate how much groups differ in size of improve-
ment, relative to the most improved group on that health-status
measure. In order to estimate the difference in change that may
have contributed to the differences in post-operative care methods
















Differences between the pathway and the conventional-care
groups, in relation to patient demographics and treatment-related
characteristics, were analysed (Table 1). The two groups differed
in terms of marital status, level of education, receiving inotropic
support and hours on mechanical ventilation. According to
Cohen’s ES ‘w’ for difference in proportions, these differences
were small [36].
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Table 1 Patients’ demographics and pre-
operative and post-operative variables in






Mean age (years) (SD) 64.93 (9.60) 64.83 (10.53) 64.89 (9.95) 0.18
Gender (%)
Male 91 (75.8%) 64 (82.1%) 155 (78.3%) 0.19
Female 29 (24.2%) 14 (17.9%) 43 (21.7%)
Marital status (%)
Married/living with partner 101 (84.2%) 56 (71.8%) 157 (79.3%) 0.03
Unmarried, widowed, divorced 19 (15.8%) 22 (28.2%) 41 (20.7%)
Educational level 95% CI
Elementary schooling 83 (70.3%) 37 (48.7%) 120 (61.9%) -35.6–7.72
Secondary schooling 19 (16.1%) 19 (25.0%) 38 (19.6%) -2.9–20.7
Higher schooling 14 (11.9%) 12 (15.8%) 26 (13.4%) -6.1–14.0
College education/university 2 (1.7%) 8 (10.5%) 10 (5.2%) 1.5–16.1
Work
Not working 87 (72.5%) 56 (71.8%) 143 (72.2%) 0.52
Working 33 (27.5%) 22 (28.2%) 55 (27.8%)
Type D
Yes 15 (12.5%) 8 (10.3%) 23 (11.6%) 0.40
No 105 (87.5%) 70 (89.7%) 175 (88.4%)
Smoking
Yes 6 (6.1%) 6 (9%) 12 (7.3%) 0.35
No 92 (93.9%) 61 (91%)
EuroSCORE 95% CI
Low risk 36 (32.1%) 28 (40.6%) 64 (35.4%) -6.0–22.9
Medium risk 46 (41.1%) 22 (31.9%) 68 (37.6%) -23.5–5.1
High risk 30 (26.8%) 19 (27.5%) 49 (27.1%) -12.6–14.1
I. Pre-operative clinical characteristics
New York Heart Associationfunctional class 95% CI
I 14 (12.3%) 7 (9.3%) 21 (11.1%) -11.9–6.0
II 25 (21.9%) 15 (20%) 40 (21.2%) -13.7–9.9
III 46 (40.4%) 36 (48%) 82 (43.4%) -6.8–22.1
IV 29 (25.4%) 17 (22.7%) 46 (24.3%) -15.2–9.6
Left ventricular ejection fraction 95% CI
>50 82 (75.2%) 53 (76.8%) 135 (78.5%) -11.3–14.4
30–50 24 (22%) 12 (17.4%) 36 (20.2%) -16.5–7.2
<30 3 (2.8%) 4 (5.8%) 7 (3.9%) -3.3–9.4
II. Pre-operative medical history:
Chronic pulmonary diseases 11 (10.1%) 7 (10.1%) 18 (10.1%) 0.59
Previous cardiac surgery 4 (3.7%) 1 (1.4%) 5 (2.8%) 0.36
Pulmonary hypertension 4 (3.7%) 2 (2.9%) 6 (3.4%) 0.57
History of angina 67 (55.8%) 48 (61.5%) 115 (58.1%) 0.26
History of hypertension 44 (36.7%) 22 (28.2%) 66 (33.3%) 0.14
History of myocardial infarction 23 (19.2%) 20 (25.6%) 43 (21.7%) 0.18
History of renal insufficiency 5 (4.2%) 4 (5.1%) 9 (4.5%) 0.50
History of diabetes 23 (19.2%) 13 (16.7%) 36 (18.2%) 0.40
III. Post-operative events
Mean overall length of stay (SD) 10.4 (5.96) 10.70 (8.30) 10.50 (6.96) 0.39
Length of stay
8 days 48 (42.9%) 35 (47.3%) 83 (44.6%) 0.33
>8 days 64 (57.1%) 39 (52.7%) 103 (55.4%)
Hospital delay* (SD) 1.80 (1.60) 2.50 (7.19) 2.08 (4.70) 0.002
Readmission rate 20 (20.2%) 7 (10.4%) 27 (16.3%) 0.07
Attending a rehabilitation programme
Yes 40 (40.4%) 36 (53.7%) 76 (45.8%) 0.06
No 59 (59.6%) 31 (46.3%) 90 (54.2%)
Discharge destination
Home 91 (84.3%) 61 (88.4%) 152 (85.9%) 0.29
Extended care facility 17 (15.7%) 8 (11.6%) 25 (14.1%)
Perioperative events
Atrial arrhythmia 34 (31.2%) 24 (34.8%) 58 (32.6%) 0.37
Ventricular arrhythmia 4 (3.7%) 2 (2.9%) 6 (3.4%) 0.57
Use of inotropes 42 (38.5%) 15 (21.7%) 57 (32%) 0.01
Re-exploration for bleeding or tamponade 8 (7.3%) 6 (8.7%) 14 (7.9%) 0.48
Time spent on mechanical ventilation (hour) 95% CI
0–6 40 (32.6%) 18 (26.1%) 58 (32.6%) -24.4–23.1
6–12 34 (31.2%) 19 (27.5%) 53 (29.8%) -17.3–10.0
12–24 14 (12.8%) 18 (26.1%) 32 (18.0%) 1.1–25.4
>24 21 (19.3%) 14 (20.3%) 35 (19.7%) -1.0–13.1
CI, confidence interval.
*Time between admission and operation in days.
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Length of stay, discharge destination and
readmission
As regards LOS and waiting time till surgery, we found that
implementing a CP decreased hospital delay (number of days the
patient spent in the hospital from admission to operation) from
2.50 (7.19) to1.80 (1.60), which was statistically significant
P = 0.002. However, according to the thresholds of Cohen’s ES d,
this difference has to be considered trivial (ES = 0.15) [36]. More-
over, there was no statistically significant difference between both
groups in relation to the number of patients exceeding 8 days of
stay in the hospital. The number of patients in the pathway group
who exceeded the 8-day LOS (fell off the pathway) was 64
(57.1%), while in the conventional-care group 39 (52.7%) of the
patients exceeded 8 days.
Furthermore, there was no statistically significant difference
between the two groups in relation to discharge destination (i.e.
discharge to home or to extended care facility), attending a reha-
bilitation programme after surgery or readmission rate, in addition,
all readmissions were to the hospital where patients had surgery.
Differences in improved HRQoL across clinical
pathway and conventional-care patients
6 months after CABG
Treatment-related improvements in both CP and conventional-care
groups were statistically significant, and these effects indicate
clinically relevant change [40] in HRQoL and anxiety. However,
patients in the CP improved relatively less than did patients in
conventional care in terms of HRQoL for the six domains of
physical and mental HRQoL: (1) physical functioning; (2) social
functioning; (3) physical role functioning; (4) mental functioning;
(5) vitality; and (6) bodily pain (Table 2). Regarding both physical
and mental component scores, conventional-care patients gained
relatively more than pathway patients did.
In contrast to these comparisons, patients in the CP improved
substantially more in terms of emotional role functioning, which
yielded the highest RE, and in general health.
No differences were found in the magnitude of decreased
depression, but the level of anxiety decreased more in
conventional-care patients than in CP patients. It was also found
that, in relation to pain, both groups improved equally with mod-
erate ES.
Outcomes in favour of patients in the conventional-care trajec-
tory were based on the difference between small ES (0.20 <0.50)
for pathway patients and moderate ES (0.50 <0.80) for
conventional-care patients, except for the domain of physical func-
tioning and physical component summary, where the ES for
conventional care was large (>0.80).
Discussion
To our knowledge this is the first controlled study to investigate the
effect of being in a pathway for CABG patient outcomes. We
controlled for variations by matching patients based on age,
gender and EuroSCORE. Although the main goal of implementing
CPs is to decrease LOS, being in a pathway did not decrease LOS
in the current study. Moreover, there was no statistically significant
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group regarding readmission rates. Patients in the pathway group,
however, had a decreased admission-operation delay (days in hos-
pital between admission and operation). Improvement in HRQoL
after CABG was realized in both groups (also for patients
who had, according to our cut-off criterion, poor health status).
We found, however, that patients receiving conventional care
improved relatively more, as compared with pathway patients, for
the six sub-domains of SF-36, but not for the domains of emotional
role functioning and general health. In addition, the conventional-
care group improved more on both the physical and mental com-
ponent summary. Regarding depression and anxiety, there was no
difference between groups in relation to depression levels, but
patients in the conventional-care group decreased in anxiety rela-
tively more when compared with the pathway-group patients.
Other studies that investigated the effect of the CABG pathway on
health-related functional status found no differences between the
two groups [15,16].
Our findings confirm that confounding individual characteristics
and differences must be taken into consideration in designing the
pathways. Factors such as ethnicity, co-morbidity, personality
traits, risk indicators and occurrence of perioperative incidences
affect patients’ perceived health status. Do CPs account for these
differences? Few authors posed the same questions and investi-
gated whether pathways should be based on the acuity of patient
conditions [41], or the presence of pre-operative risk factors and
perioperative incidences [42]. Yet they come to the same conclu-
sion, and that was when designing a pathway, all these factors need
to be taken into consideration. Moreover, a systematic review by
Dy and colleagues [43], focused on determining the effectiveness
of CPs, concluded that ‘clinical pathways tended to be effective
when applied to procedures with lower complexity/severity of
illness.’ They also stated that ‘because pathways tend to be rela-
tively inflexible and oriented toward patients with predictable
course of care, they may not work well when care is more variable
as in intensive care unit.’
Strengths and limitations
The strength of this study lies in the fact that we compared out-
comes of a CP with a control group under conventional care, and
controlled for potential confounders, namely, age, gender and
EuroSCORE through matching. The limitations of the study lie in
the fact that: (1) randomizing individual patients (or surgeons) to a
CP or conventional care in the same hospital was inappropriate as
this would induce contamination bias; (2) at the start of the current
study there was no controlled study that evaluated the effects of CP
on health-related functional status, which therefore made it impos-
sible to perform a power analysis; and that (3) although reminders
were sent at baseline for non-responders and at follow-up for
dropouts, 23% of patients declined to participate at baseline and
12% dropped out at follow-up.
Conclusion
In conclusion, the aim of designing and implementing pathways is
to decrease LOS and subsequently decrease costs, while at the same
time maintaining quality of care and improving patient outcomes.
Our findings suggest that these aims were not fulfilled in the CABG
pathway. It has been argued that CPs address the ‘ideal patient’ [1],
which we tend to agree with, and thus in light of these findings, we
recommend that when designing a CP, all patient-related character-
istics, risk indicators, along with physiological status, be taken into
consideration. Moreover, pathways should be designed and LOS set
based on patients’ acuity of illness and a follow-up period should be
added for these patients in order to ensure optimum outcome. In
addition, we also recommend incorporating HRQoL measurement
as part of a routine assessment of patient health, both pre- and
post-operative, because this will provide a clear view of the
patient’s perception of his physical functioning and mental health,
which will, in turn, have a great impact on planning care and
counselling patients. Further research is needed to evaluate the
effects of CP when designed in such a way.
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